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Abstract
Background: Reports from the 2009 H1N1 influenza A virus (2009 H1N1) pandemic indicate
increased mortality in obese patients hospitalized with pneumonia. However, articles published
prior to the pandemic have suggested that obesity may be a protective factor for mortality in
these patients. The objective of this study was to compare the impact of obesity on mortality
in hospitalized patients with pneumonia due to the 2009 H1N1 versus pneumonia due to other
etiologies.
Methods: This was a secondary analysis of the CAPO international cohort study. Study groups
were defined as follows: Group One, pneumonia due to 2009 H1N1: Patients hospitalized with
pneumonia after March 2009 with a positive RT-PCR for 2009 H1N1 and Group Two, pneumonia
due to other etiologies: Patients hospitalized with pneumonia before March 2009. Body Mass
Index (BMI) was used to predict the influence of obesity on mortality. The effect of BMI on mortality
was analyzed using a propensity-adjusted logistic regression model.
Results: From the total of 897 patients, 215 (24%) had pneumonia due to 2009 H1N1. After
adjustment, increased BMI was associated with increased mortality in patients with pneumonia
due to 2009 H1N1 and with decreased mortality in patients with pneumonia due to other etiologies.
Conclusions: Obesity is associated with poor outcomes in patients with pneumonia due to 2009
H1N1 but is protective in patients with pneumonia due to other etiologies. Defining the molec-
ular mechanisms by which obesity influences outcomes in patients with pneumonia may help to
develop novel therapeutic strategies.
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1 Introduction
Obesity is a growing pandemic. In the USA, 33% of adults are
overweight, 34% are obese, and six percent are extremely obese.1
In the general population, obesity is clearly associated with in-
creased morbidity and mortality.2,3 However, in the acutely ill
hospitalized patient, controversy exists regarding the impact of
obesity on patient mortality. Recent reports of acutely ill hospital-
ized patients with pneumonia due to 2009 H1N1 influenza A virus
(2009 H1N1) suggested that increased BMI was associated with
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poor outcomes.4–6 Obese patients with pneumonia due to 2009
H1N1 were more likely to require ICU care due to severe pneu-
monia with respiratory failure and acute respiratory distress syn-
drome (ARDS).7 On the other hand, a meta-analysis published in
2009 indicated that hospitalized, acutely ill, obese patients were
protected from poor outcomes.8 This meta-analysis included a
total of 88,051 obese and non-obese patients from 22 studies.
Mortality of obese patients was statistically lower than in patients
who were not obese. Several of these studies included patients
with pneumonia. Since all of the analyzed studies predated the
emergence of the 2009 H1N1 pandemic, we can conclude that
patients with pneumonia included in these studies were infected
with pathogens other than the 2009 H1N1 influenza A virus. A
more recent publication reported decreased mortality in obese
hospitalized patients with pneumonia due to Streptococcus pneu-
monia and Haemophilus influenza.9
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Table 1 Characteristics of hospitalized patients with pneumonia enrolled in the CAPO international cohort study by etiology of pneumonia
Pneumonia due to Pneumonia due to
Variable 2009 H1N1 Other Etiologies P-value
n=215 n=682
n (%) n (%)
Age ≥65 26 (12.1) 372 (54.5) <0.001
Age, Mean (SD) 43.9 (17.4) 65.2 (16.8) <0.001
Male Gender 97 (45.1) 551 (80.8) <0.001
BMI, Mean (SD) 27.8 (7.7) 25.9 (5.2) <0.001
BMI Class
>30.0 kg/m2 (Obese) 62 (28.8) 152 (22.3)
25.0-29.9 kg/m2 (Overweight) 42 (19.5) 170 (24.9) 0.082
18.5-24.9 kg/m2 (Normal Weight) 111 (51.6) 260 (52.8)
Nursing Home Resident 2 (0.9) 36 (5.7) 0.004
Diabetes 30 (14.1) 170 (26.6) 0.002
COPD 27 (12.6) 256 (37.5) <0.001
HIV Disease 1 (0.5) 100 (14.7) <0.001
Congestive Heart Failure 17 (8) 140 (22.2) <0.001
Liver Disease 5 (2.3) 46 (7.2) 0.009
Neoplastic Disease 6 (2.8) 77 (12.2) <0.001
Renal Disease 11 (5.2) 89 (14) 0.001
Cerebrovascular Accident 2 (0.9) 83 (13.2) <0.001
Albumin ≤3.5 g/dl 50 (59.5) 120 (80.5) <0.001
Blood urea nitrogen ≥30 mg/dl 67 (33.3) 165 (28.1) 0.157
Sodium <130 mmol/L 23 (10.7) 78 (11.4) 0.765
PaO2 <60 mm Hg 142 (66) 323 (47.4) <0.001
Temperature <95◦C or >104◦C 3 (1.4) 24 (3.5) 0.112
Heart Rate ≥125 Beats/Min 30 (14.1) 78 (11.5) 0.304
Respiratory Rate >30 Breaths/Min 59 (27.7) 72 (10.8) <0.001
Systolic Blood Pressure <90 mm Hg 10 (4.7) 38 (5.6) 0.601
Altered Mental Status 29 (13.5) 90 (13.2) 0.912
ICU Admission 67 (31.6) 89 (14) <0.001
PSI Risk Class IV or V 43 (20) 359 (52.6) <0.001
CURB-65 Score II, III or IV 84 (39.1) 146 (21.5) <0.001
Based on the current literature, it can be hypothesized that the
impact of obesity on the clinical outcomes of hospitalized patients
with pneumonia may be different based on the etiologic agent.
Obese patients with pneumonia due to 2009 H1N1 may be at high
risk for mortality, whereas obese patients with pneumonia due to
other etiologies may be at a lower risk for mortality. The aim
of the present study was to compare the effect of obesity on the
mortality of hospitalized patients with pneumonia due to 2009
H1N1 versus patients with pneumonia due to other etiologies.
2 Materials & Methods
2.1 Study Design and Patients
This was a secondary data analysis of patients with pneumo-
nia enrolled in the Community-Acquired Pneumonia Organiza-
tion (CAPO) International Cohort Study.10 Data collection for the
CAPO study started in April 2000. The study is currently enrolling
patients hospitalized with pneumonia from 55 centers in 20 coun-
tries. Copies of the study protocol and data collection form are
available at the study website.11 Institutional review board ap-
proval was obtained from all participating institutions.
2.2 Inclusion criteria
1. Patients hospitalized with pneumonia fulfilling the following
criteria: Presence of a new pulmonary infiltrate on chest ra-
diograph at the time of hospital admission and either a new
or increased cough with or without sputum production, an
abnormal temperature (< 35.6◦C or > 37.8◦C), or an ab-
normal serum leukocyte count (e.g., leukocytosis, left shift,
or leukopenia).12
2. Patients with available data to calculate body mass index
(BMI).
2.3 Study Groups
Patients were classified into two groups:
• Group A, Pneumonia due to 2009 H1N1: Patients hospitalized
with pneumonia after May 2009 with an RT-PCR test positive
for 2009 H1N1 influenza A virus.
• Group B, Pneumonia due to other etiologies: Patients hospi-
talized with pneumonia before May 2009.
2.4 Predictor Variable
The predictor variable was Body Mass Index (BMI), defined as the
weight in kilograms divided by the square of the height in meters
(kg/m2).
2.5 Outcome Variable
The outcome variable was mortality for any cause during the hos-
pitalization.
2.6 Confounding variables
A total of 24 confounding variables were collected including pa-
tient demographics, comorbidities and laboratory characteristics.
2.7 Statistical analysis
Baseline patient characteristics between those with pneumonia
due to 2009 H1N1 versus those with pneumonia due to other
etiologies were compared using the chi-squared or Fisher’s Ex-
act tests for categorical variables and the Mann-Whitney U-test
for continuous variables. To examine the adjusted effect of the
etiology of pneumonia on patient mortality for a given BMI,
a propensity-adjusted logistic regression model was used. The
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Fig. 1 Propensity-adjusted risk of mortality by body mass index for hospitalized patients in the CAPO international cohort with pneumonia due to
H1N1 compared to hospitalized patients with pneumonia due to other etiologies.
propensity score adjustment methodology allows for the condens-
ing of multiple confounding variables into one score. This may
reduce error from including too many confounding variables in
a multivariate regression model when the outcome of interest
in the study population is infrequent. Although initially devel-
oped for models examining treatment effects, this methodology
has shown validity for controlling for confounding when examin-
ing non-treatment predictor variables.13 All of the variables listed
in Table 1 with P-values of≤0.15 were used to create the propen-
sity score. Since BMI was the outcome of the creation of the
propensity score, it was not included as an independent variable
in its creation. As it was not expected that the propensity score
predicted mortality linearly, the score was partitioned into five
equal sized categories.14 A logistic regression model was then
created to determine the propensity-adjusted risk of mortality for
a given BMI. The final model included the following variables:
BMI, pneumonia etiology (2009 H1N1 versus other etiologies),
an interaction term between the etiology of pneumonia and BMI,
and the five levels of the categorized propensity score. The in-
teraction term was included in the model to determine if the
propensity-adjusted risk of mortality was statistically different for
each etiology of pneumonia. P-values of ≤0.05 were considered
statistically significant. SAS v9.2 (SAS Inc., Cary, NC) and Med-
Calc v11 (Mariakerke, Belgium) were used for all analyses.
3 Results
3.1 Study Patients
A total of 897 patients were included in the study. Mean age of
all patients was 60 years (SD=19), and 648 patients were male
(72%). According to BMI, 53% of patients were within the nor-
mal BMI range, 24% of patients were overweight (BMI: 25-29.9
kg/m2); and 24% of patients were obese (BMI>30 kg/m2). Of
the obese patients, 61% had a BMI between 30-35 kg/m2; 18%
had a BMI between 35-40 kg/m2; and 21% had a BMI > 40
kg/m2.
A total of 215 (24%) patients had a confirmed diagnosis of 2009
H1N1 influenza A virus. Characteristics of the study population
according to the etiology of pneumonia are included in Table 1.
All of the patients received adequate antibiotic therapy according
to national guidelines. Appropriate antiviral treatment was given
to 191 of the patients with confirmed 2009 H1N1 influenza A
virus infection (189 with oseltamivir and 2 with zanamivir). A
total of 60 of these patients (29%) were treated with steroids.
3.2 Study Outcomes
A total of 36 (42%) patients with pneumonia due to 2009 H1N1
died, compared with 179 (22%) patients with pneumonia due to
other etiologies (P<0.001). The propensity-adjusted risk curves
indicating the predicted risk of mortality in relation to the BMI for
each study arm are shown in Figure 1. The adjusted risk of mor-
tality increased with increased BMI for patients with pneumonia
due 2009 H1N1. Contrary to this, the adjusted risk of mortality
decreased with increased BMI for patients with pneumonia due
to other etiologies. There was a statistically significant difference
between the risks of mortality by BMI for the two study groups
(P<0.001).
4 Discussion
This study indicates that the impact of obesity on the mortality
of hospitalized patients with pneumonia is influenced by the eti-
ologic agent. In patients with pneumonia due to 2009 H1N1,
obesity is associated with increased mortality. On the other hand,
in patients with pneumonia due to other etiologies, obesity has a
protective effect on mortality.
Several investigators have reported an association of obesity with
poor outcomes in patients with pneumonia infected with 2009
H1N1.4–7 Animal studies indicate that the production of inter-
feron is significantly decreased in diet-induced, obese mice when
compared to lean, control animals.15,16 Decreased production of
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interferon in obese patients may explain the poor outcomes asso-
ciated with pneumonia due to 2009 H1N1 influenza A virus.
The role of obesity in the outcomes of pneumonia patients in-
fected with pathogens other than 2009 H1N1 influenza A virus
have been reported in three prior publications. First, a longitudi-
nal study of pneumonia hospitalizations and mortality including
5,677 men and women 55 years of age and older found that, af-
ter adjusting for chronic conditions, the risk of pneumonia death
was lower in those with the highest BMI.17 Second, a study of
110,792 patients found that a high BMI (≥25Kg/m2) was pro-
tective for pneumonia-related mortality in middle-aged and el-
derly community residents.18 Third, a recent study from a sin-
gle center indicated a decreased risk of pneumonia death in pa-
tients with higher BMI infected with Streptococcus pneumoniae
or Haemophilus influenzae.19 Our findings are in agreement with
these three studies indicating that obesity is a protective factor for
mortality in patients with pneumonia who are not infected with
2009 H1N1 influenza A virus. It is unclear why obese patients
may be protected from poor outcomes when pneumonia is due to
a bacterial pathogen.
Obese patients have a low-grade chronic inflammatory state
produced by both classic cytokines and adipose tissue released
adipocytokines such as leptin or adiponectine.20,21 This abnormal
inflammatory state is known to be detrimental to several organ
systems, and may accelerate the progression of chronic diseases
such as atherosclerosis and diabetes. It can be speculated that
the abnormal cytokine milieu present in obese patients may be
protecting against the systemic inflammatory response that char-
acterizes severe bacterial pneumonia.
Our study has several limitations. Although there are more than
7,000 patients in the CAPO database, data on BMI was available
in only 17% of these cases. Lack of BMI in databases of patients
with infections has been mentioned as an important limitation
in the study of the role of obesity in patients with infections.22
Timing of antiviral therapy has been considered an important de-
terminant of outcomes in patients with pneumonia due to 2009
H1N1.23 In our database, the timing of initiation of symptoms
prior to admission to the hospital was not available in a signifi-
cant number of patients. Because of this, timing of initiation of
symptoms to initiation of antiviral therapy was not available. Fi-
nally, several variables that are not available in the database may
confound the relationship between obesity and mortality in our
patients. This may bias the results.
Our data were strengthened by the following factors: First, the
data represents patients from multiple countries, thereby increas-
ing generalizability. Second, we used RT-PCR for confirmatory
diagnosis of 2009 H1N1. By excluding patients enrolled in the
CAPO database after the start of the 2009 H1N1 pandemic, we
can reasonably assume that no patient in the control group was
infected with this virus.
In conclusion, this study indicates that obesity is an independent
prognostic factor for mortality in patients with pneumonia. El-
evated BMI is associated with a significant increase in mortality
in hospitalized patients with pneumonia due to 2009 H1N1 in-
fluenza A virus. On the other hand, an elevated BMI is a protec-
tive factor for mortality in hospitalized patients with pneumonia
due to etiologies other than 2009 H1N1 influenza. The pathogen-
esis underlying this opposite effect of obesity on mortality in rela-
tion with the etiology of pneumonia is unknown. Understanding
the causes that place an obese host with pneumonia at increased
or decreased risk for mortality according to the etiology of pul-
monary infection may help to develop new treatment strategies
for obese patients with acute infections.
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